Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Richard Head and Jennifer Redfearn
  • May 15, 2018
  • Awards, News

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research and consultancy work.

read more »

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI (Best of Business Intelligence) Awards for our combined work in helping to reverse the fortunes of one of their established products, which up until recently had been suffering from declining market growth in the UK.

read more »

Director Richard Head is joint winner of the 2017 EphMRA President's Award

Director Richard Head is joint winner of the 2017 EphMRA President's Award

We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research.

According to EphMRA, Richard was nominated because he has been a long-standing supportive member of the Board who is always happy to volunteer and share his experiences. Richard is also an Associate Member on the EphMRA Board a position he has held for the last 4 years
 

read more »

Richard Head elected Associate Member to the EphMRA Board

Richard Head elected Associate Member to the EphMRA Board

We are pleased to announce that Director Richard Head has been re-elected to the EphMRA Executive Board 2015 following a vote by other Associate Members.

Richard has 11 years’ experience in international market research, covering qualitative and quantitative across a variety of therapy areas. He is championing innovation at Research Partnership, and in his time as board member, Richard has been an active voice for Associate Members. The board, which includes both pharmaceutical company and supplier side representation, helps to determine where EphMRA should focus in order to best benefit its members.For 2015-17, Richard aims to advance his existing efforts, and commented, “I am delighted to continue to represent all Associate Members, from full service agencies to syndicated data suppliers and fieldwork providers, on the EphMRA board. I am passionate about maintaining the highest standards in market research, as expected from EphMRA, advocating the use of innovative technologies and solutions. I look forward to working with my fellow board members to advance EphMRA’s strategic goals.” Thank you to everyone that voted and congratulations to Richard on his reappointment.
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »

  • Posted by Julie Denny
  • October 8, 2014
  • Awards

Research Partnership wins Best Business Award

Research Partnership wins Best Business Award

Research Partnership is delighted to have won a Best Business Award for “Best small to medium size business”.

The company has been recognised for its successful ability to expand into new markets and for establishing new business solutions. Commenting on the award, the chairman of judges said: “Research Partnership has grown to be one of the largest healthcare market research companies with offices around the world as it has kept one step ahead by constant expansion into new territories. It has also invested significantly in mobile technology solutions to develop new tools, such as Rx Rationale and Conference Live, in order to provide pharmaceutical company clients with new and improved ways of gaining insights. Many congratulations to Research Partnership for achieving highly impressive growth and pioneering new advances.”

read more »